Atlas Venture logo

Atlas Venture

North America, Massachusetts, United States, Cambridge

Description

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Investor Profile

Atlas Venture has made 587 investments, with 13 in the past 12 months and 27% as lead.

Stage Focus

  • Series A (28%)
  • Series B (24%)
  • Seed (13%)
  • Series Unknown (12%)
  • Series C (12%)
  • Series D (4%)
  • Series E (2%)
  • Post Ipo Equity (2%)
  • Private Equity (1%)
  • Debt Financing (1%)

Country Focus

  • United States (82%)
  • United Kingdom (10%)
  • Germany (2%)
  • Canada (1%)
  • France (1%)
  • Switzerland (1%)
  • Ireland (1%)
  • Italy (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Software
  • Medical
  • Pharmaceutical
  • Mobile
  • Internet
  • Enterprise Software
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Atlas Venture frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 25
M
North America, California, United States, San Francisco
Co-Investments: 18
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 18
NextView Ventures
North America, New York, United States, New York
Co-Investments: 18
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 20
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 17
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 20
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 24
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 19
Accel
North America, California, United States, Palo Alto
Co-Investments: 17

Which angels does Atlas Venture often collaborate with?

AP
North America, Massachusetts, United States, Boston
Shared Deals: 2
CL
North America, Massachusetts, United States, Boston
Shared Deals: 3
TD
North America, Massachusetts, United States, Boston
Shared Deals: 3
DS
North America, Massachusetts, United States, Boston
Shared Deals: 4
BG
North America, Washington, United States, Seattle
Shared Deals: 5
WW
North America, Massachusetts, United States, Boston
Shared Deals: 2
JC
North America, Massachusetts, United States, Boston
Shared Deals: 5
NR
North America, California, United States, San Francisco
Shared Deals: 4
SM
Europe, England, United Kingdom, London
Shared Deals: 2
ML
North America, California, United States, San Francisco
Shared Deals: 3

What are some of recent deals done by Atlas Venture?

Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series CJan 15, 2025
Amount Raised: $92,000,000
nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
Trace Neuroscience

South San Francisco, California, United States

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

BiotechnologyHealth CareLife Science
Series ANov 12, 2024
Amount Raised: $101,000,000
Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series UnknownOct 22, 2024
Amount Raised: $82,000,000
Judo Bio

Cambridge, Massachusetts, United States

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series AOct 7, 2024
Amount Raised: $75,000,000
Triveni Bio

Watertown, Massachusetts, United States

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

BiotechnologyHealth CareMedicalTherapeutics
Series BOct 2, 2024
Amount Raised: $115,000,000
Kailera Therapeutics

Waltham, Massachusetts, United States

Kailera Therapeutics is a clinical-stage biotechnology company that provides therapies for treating obesity and related diseases.

BiotechnologyPharmaceuticalTherapeutics
Series AOct 1, 2024
Amount Raised: $400,000,000
PHINXT Robotics

London, England, United Kingdom

PHINXT Robotics enables warehouses of any size to deploy autonomous robots as needed, with no expertise required.

RoboticsWarehouse AutomationWarehousing
SeedAug 6, 2024
Amount Raised: $2,555,502
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
Series BJul 19, 2024
Amount Raised: $60,300,000
Scorpion Therapeutics

Boston, Massachusetts, United States

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine
Series CJul 16, 2024
Amount Raised: $150,000,000